A Twice Daily Posaconazole Dosing Algorithm for Children With Chronic Granulomatous Disease
The Pediatric Infectious Disease Journal, 08/29/2011
Clinical Article
Welzen ME et al. – A twice daily dosing algorithm based on allometric scaling (body–weight based) for Posaconazole (PSZ) results in adequate exposure and appears to be safe in children with chronic granulomatous disease.
- Posaconazole (PSZ) may be an attractive alternative for antifungal prophylaxis in children with chronic granulomatous disease.
- Experience with PSZ in pediatric patients is limited, and no specific dose recommendations exist.






